Today's Top Gainer
| SYMBOL | CMP | Chg (%) |
|---|---|---|
Note:Top Gainer - Nifty 50 More
Jagsonpal Pharmaceuticals Ltd - Share Price
JAGSNPHARM
Financials
News & Updates
Meeting Type
Meeting Date
| Resolution Type | Description Of Resolution | IiAS Recommendation |
|---|
Peer Comparison
| Name | LTP | PE | Mar Cap | NP Qtr | Div. Yld | Sales Qtr | BV |
|---|---|---|---|---|---|---|---|
| Sun Pharmaceuticals Industries Ltd | 439.25 | 40.24 | 105,246.83 | 823.16 | 0.63 | 3,215.01 | 98.33 |
| Divis Laboratories Ltd | 1,842.00 | 37.89 | 48,844.89 | 352.83 | 0.87 | 1,403.92 | 266.77 |
| Dr Reddys Laboratories Ltd | 2,821.50 | 18.65 | 46,904.85 | 1,365.10 | 0.71 | 3,435.30 | 852.70 |
| Cipla Ltd | 461.25 | 15.76 | 37,195.20 | 737.38 | 0.65 | 3,230.08 | 209.72 |
| Biocon Ltd | 292.35 | 117.96 | 35,106.00 | 106.10 | 0.17 | 523.90 | 59.29 |
Figures of Market Capital(Mar Cap), Quaterly Net Profit(NP Qtr) and Quaterly Sales(Sales Qtr) are in Cr.
Summary & Reports
No Company Summary found
Registered Office
T-210 J,Shahpur Jat,New Delhi, New Delhi,110049
Tell. : +91-011-46181100/46109900
Website : http://www.jagsonpal.com
Email : cs@jagsonpal.com
Registrar Office
F-65 1st Floor, Phase-I, New Delhi-110020 INDIA
Tell. : +91-11-41406149-52
Website : www.mcsdel.com
Email : mcsdel@vsnl.com
Reports by jagsonpal-pharmaceuticals-ltd
Latest Release by jagsonpal-pharmaceuticals-ltd
Result Express
Shareholding Snapshot
Loading ...
| Sep - 2019 | |
|---|---|
| Promoter | - |
| Foreign | 0.00% |
| Indian | 70.34% |
| Total Promoter | 70.34% |
| Non Promoter | - |
| Institutions | 0.00% |
| Non-Institutions | 29.66% |
| Total Non-Promoter | 29.66% |
| Custodian | 0.00% |
| Total | 100% |
Corporate Action
Purpose
Board Meeting
Exp. Date
14 Nov 2019
Annc. Date
05 Nov 2019
JAGSONPAL PHARMACEUTICALS LTD.has informed BSE that the meeting of the Board of Directors of the Com... More
Purpose
AGM
Exp. Date
30 Sep 2019
Annc. Date
05 Sep 2019
AGM 30/09/2019Pursuant to Section 91 of the Companies Act, 2013, the Register of Members and Share T... More
Purpose
Dividend
Annc. Date
28 May 2019
Effective. Date
20 Sep 2019
Divi. Type
Final
Divi.(%)
5
Divi. Amt.
0.25
Jagsonpal Pharmaceuticals Ltd has informed BSE that the Board of Directors of the Company at its Mee... More
